Bisphosphonate treatment in inaccessible osteoid osteomas: An alternative therapeutic approach.

Joint Bone Spine

Rheumatology Department, Sainte-Marguerite Hospital, AP-HM, 13009 Marseille, France; Aix-Marseille University, 13284 Marseille, France.

Published: December 2023

Introduction: Osteoid osteoma is a benign osteogenic tumour traditionally treated by surgical excision or percutaneous CT-guided procedures. We describe three cases of osteoid osteomas of which the locations were difficult to access, or for which the procedure was potentially unsafe, involving treatment with zoledronic acid infusions.

Case Description: We report here three male 28-to-31-year-old patients with no medical history who had osteoid osteomas located at the second cervical vertebra, the femoral head, and the third lumbar vertebra respectively. These lesions were responsible for inflammatory pain requiring daily treatment with acetylsalicylic acid. Given the impairment risk, all of the lesions were ineligible for surgical or percutaneous treatment. Patients were successfully treated by 3 to 6 monthly zoledronic acid infusions. All patients experienced complete relief of their symptoms allowing aspirin discontinuation, without any side effects. In the first two cases, CT and MRI control showed nidus mineralization and bone marrow oedema regression, correlating with the pain decrease. After 5years of follow-up, there had been no recurrence of the symptoms.

Conclusion: In these patients, monthly 4mg zoledronic acid infusions have been safe and effective in the treatment of inaccessible osteoid osteomas.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbspin.2023.105589DOI Listing

Publication Analysis

Top Keywords

osteoid osteomas
16
zoledronic acid
12
treatment inaccessible
8
inaccessible osteoid
8
acid infusions
8
osteoid
5
bisphosphonate treatment
4
osteomas
4
osteomas alternative
4
alternative therapeutic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!